共 30 条
- [21] Timing of bone marrow cell therapy is more important than repeated injections after myocardial infarctionCARDIOVASCULAR PATHOLOGY, 2011, 20 (04) : 204 - 212Zhang, YanSievers, Richard E.Prasad, MeghaMirsky, RachelShih, HenryWong, Maelene L.Angeli, Franca S.Ye, JianqinTakagawa, JunyaKoskenvuo, Juha W.Springer, Matthew L.Grossman, WilliamBoyle, Andrew J.Yeghiazarians, Yerem
- [22] Parental decisions to terminate/continue following abnormal cytogenetic prenatal diagnosis. ''What'' is still more important than ''when''AMERICAN JOURNAL OF MEDICAL GENETICS, 1996, 61 (04): : 353 - 355Evans, MISobiecki, MAKrivchenia, ELDuquette, DADrugan, AHume, RFJohnson, MP
- [24] Timing of Thoracic Radiotherapy Is More Important Than Dose Escalation in Patients with Limited-Stage Small Cell Lung CancerJOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1802 - S1803Hu, X.Xia, B.Bao, Y.Xu, Y.Wang, J.Ma, H.Jin, Y.Fang, M.Tang, H.Chen, M.Dong, B.Fu, X.Chen, M.
- [25] LONG-TERM RISK OF RELAPSE IN PATIENTS WITH CHILDHOOD-ONSET LANGERHANS CELL HISTIOCYTOSIS: A REPORT OF TWO ADULT CASES WHO RELAPSED AT MORE THAN 15-YEAR INTERVALSPEDIATRIC BLOOD & CANCER, 2020, 67 : S30 - S30Shioda, YokoSakamoto, KenichiShirai, RyotaKato, MotohiroOsumi, TomooTomizawa, DaisukeMiyazaki, OsamuMatsumoto, Kimikazu
- [26] Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studiesSTRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (02) : 172 - 181Hu, XiaoXia, BingBao, YongXu, Yu-jinWang, JinMa, Hong-lianPeng, FangJin, YingFang, MinTang, Hua-rongChen, Meng-yuanDong, Bai-qiangJin, Jia-nanFu, Xiao-longChen, Ming
- [27] Correction to: Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studiesStrahlentherapie und Onkologie, 2020, 196 : 405 - 405Xiao HuBing XiaYong BaoYu-jin XuJin WangHong-lian MaFang PengYing JinMin FangHua-rong TangMeng-yuan ChenBai-qiang DongJia-nan JinXiao-long FuMing Chen
- [28] EARLY MORTALITY IN LANGERHANS CELL HISTIOCYTOSIS III (LCH-III) TRIAL SUGGESTS SOME PATIENTS REQUIRE MORE EFFECTIVE THERAPY EVEN BEFORE THE 1ST RESPONSE ASSESSMENT POINT AT 6 WEEKSPEDIATRIC BLOOD & CANCER, 2020, 67 : S16 - S16Visser, JohannesPotschger, UlrikeThiem, ElfriedeMinkov, MilenArico, MaurizioAstigarraga, ItziarBraier, JorgeDonadieu, JeanGrois, NicoleGadner, HelmutHenter, Jan-IngeJanka-Schaub, GrittaMcClain, KennethWeitzman, SheilaWindebank, KevinLadisch, Stephan
- [29] Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies (vol 196, pg 172, 2020)STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (04) : 405 - 405Hu, XiaoXia, BingBao, YongXu, Yu-jinWang, JinMa, Hong-lianPeng, FangJin, YingFang, MinTang, Hua-rongChen, Meng-yuanDong, Bai-qiangJin, Jia-nanFu, Xiao-longChen, Ming
- [30] Timing of thoracic radiotherapy is more important than dose intensification in patients with limited-stage small cell lung cancer: a parallel comparison of two prospective studies; [Der Zeitpunkt der thorakalen Strahlentherapie ist wichtiger als die Dosisintensivierung bei Patienten mit limitiertem Stadium des kleinzelligen Lungenkarzinoms: Ein paralleler Vergleich von zwei prospektiven Studien]Strahlentherapie und Onkologie, 2020, 196 (2) : 172 - 181Hu X.Xia B.Bao Y.Xu Y.-J.Wang J.Ma H.-L.Peng F.Jin Y.Fang M.Tang H.-R.Chen M.-Y.Dong B.-Q.Jin J.-N.Fu X.-L.Chen M.